Optimal effect-site concentration of remifentanil for minimizing cardiovascular changes caused by fiberoptic nasotracheal intubation.

Eun-Jung KimHyun-Wook JeonTae-Kyun KimSeung-Hoon BaekJi-Uk YoonJi-Young Yoon

Published in: Journal of dental anesthesia and pain medicine (2015)

The EC50 of remifentanil for minimizing the cardiovascular changes and side effects associated with fiberoptic nasotracheal intubation was 3.11-3.43 ng/mL during propofol TCI anesthesia with a Ce of 4 ug/mL.

Keyphrases

cardiac arrest
energy transfer
quantum dots